Manulife (MFC) Q2 2026 earnings review
Top-Line Momentum Shines, but Canada Proves a Laggard
Manulife delivered a robust Q2 2026, punctuated by a 21% acceleration in APE sales and a 16% jump in Core EPS. The growth narrative was underpinned by exceptional execution in Asia and a sharp profitability rebound in the U.S. segment, which overcame prior quarters' claims and ECL headwinds. However, the geographic performance was mixed: Canada reversed its trend, posting a 10% decline in core earnings due to unfavorable group insurance claims. Despite Global WAM retail and retirement outflows, institutional wins and higher equity markets boosted total AUMA by 6% year-to-date. Manulife's announcement of a new long-term care reinsurance transaction further underscores management's commitment to de-risking the balance sheet.
🐂 Bull Case
Asia APE sales jumped 21% and New Business CSM grew 17%, driven by broad-based expansion in Hong Kong, Singapore, and Japan. The segment continues to prove highly accretive with a robust 36.3% NBV margin.
U.S. core earnings surged 55% YoY, completely reversing the elevated mortality and ECL provisions that plagued recent quarters, signaling that underwriting fundamentals remain intact.
🐻 Bear Case
Canada core earnings fell 10% YoY. Unfavorable claims experience coupled with elevated operating expenses for transformational investments eroded domestic profitability.
Despite a massive institutional mandate win, the segment suffered a $4.9B outflow in Retirement and a $1.4B outflow in Retail, driven by elevated plan redemptions and market-induced withdrawals.
⚖️ Verdict: 🟢
Bullish. The 16% core EPS growth, strong expense discipline (44.5% efficiency ratio), and normalization of U.S. claims far outweigh the localized weakness in Canada and the predictable wealth outflows tied to high market balances.
Key Themes
Asia Segment Broad-Based Acceleration
Asia remains the primary growth catalyst. APE sales reached US$1.49B, up 21% YoY, accelerating significantly. Hong Kong APE expanded 37% due to savings product demand, while Japan APE skyrocketed 57% via broker channel adoption of investment-linked products. This translated to a 13% expansion in New Business Value (US$506M) and firmly solidifies Asia as the principal margin driver.
U.S. Claims Rebound
U.S. profitability is reversing from a major headwind to a tailwind. Core earnings jumped 55% to $301M (CAD), primarily due to improved claims experience in both life and long-term care (LTC), along with a significantly lower Expected Credit Loss (ECL) provision compared to the credit migration hit taken in 25Q2.
Canada Flips to Laggard
Canada emerged as a clear laggard this quarter. While APE sales increased 23%, core earnings reversed trajectory, falling 10% YoY to $379M. The compression was directly caused by unfavorable claims experience in Group and Individual Insurance, compounded by elevated expenses aimed at supporting the growing business and customer experience upgrades. A disconnect between top-line sales and bottom-line earnings is a definitive red flag.
Global WAM Outflows in Core Channels
While overall net flows were positive at $0.4B, reversing the trend of three consecutive negative quarters, the underlying mix is concerning. Retirement net outflows hit $4.9B (compared to $2.0B inflows a year ago) largely due to higher plan redemptions and participants cashing out elevated market balances. Retail outflows also remained negative at $1.4B. Growth is currently entirely dependent on lumpy Institutional Asset Management inflows ($6.7B).
ALDA Portfolio Underperformance
Despite a total market experience gain of $201M (driven by public equities), Alternative Long-Duration Assets (ALDA) remain a structural drag. Management reported continued lower-than-expected returns across infrastructure, private equity, and real estate, dragging down comprehensive investment results.
AI Execution and Process Automation
Manulife continues to integrate technology deeply into its operations. The Manulife Automated Underwriting Decision Engine (MAUDE) in Canada saw a 60% YoY increase in policies processed. Furthermore, the company was ranked the #1 life insurer for AI maturity by the Evident AI Index, validating the measurable operational leverage gained from its AI investments.
Other KPIs
Improving. The ratio fell by 100 basis points from 45.5% in 25Q2. Core expenses are growing at a slower rate than pre-tax core earnings, signaling successful operational leverage and disciplined expense management despite ongoing AI investments.
Accelerating. Up 110 basis points from 30.1% a year ago. Margins expanded largely due to higher net fee income from elevated average AUMA, as well as contributions from the Manulife | Comvest business, offsetting the margin drag from the eMPF transition in Hong Kong.
Accelerating. Up 16% YoY on a constant exchange rate basis. Crucial metric for future earnings capacity. Asia contributed $777M of this total, underpinning the quality of Manulife's newly underwritten business.
Key Questions
Canada Group Claims Volatility
Canada core earnings fell 10% due to unfavorable claims in Group and Individual Insurance. Can you isolate how much of this was a one-off severity spike versus a structural deterioration in incidence rates?
Global WAM Retirement Bleed
Retirement saw a massive $4.9B outflow. How much of this is structural churn from older demographics capitalizing on all-time high market balances, and when do you expect these withdrawal rates to normalize?
ALDA Return Timelines
With another quarter of lower-than-expected returns in the ALDA portfolio (real estate, private equity, infrastructure), are you considering structural downward revisions to your long-term return assumptions for these asset classes?
Hong Kong Broker Transition
With Hong Kong APE surging 37%, mostly in savings products, has the broker channel entirely completed its adjustment to the new regulatory limits on return illustrations that caused softness late last year?